CVS/Caremark Corporation
Reports from CVS/Caremark Corporation detail the recent activities
Published in Lab Business Week, June 3rd, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at CVS/Caremark Corporation.
Report 1: Consistent with its previously announced plans, CVS/Caremark Corporation (NYSE: CVS) announced the commencement of a tender offer to purchase up to 150,000,000 shares, or about 10%, of its outstanding common stock at a price of $35.00 per share. The offer to purchase shares, which is not conditioned upon any minimum number of shares being tendered, commenced today and will expire at 12:00 midnight, New York City time on April 24, 2007, unless...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2007-06-03)
More Articles from Lab Business Week
- Best Lab Deals, Inc.
BLD International Hosting LabStock 2007 - Bio-Rad Laboratories
Bio-rad Receives Three Life Science Industry Awards - Biotechnology
Scientists at Tochigi Research Laboratories describe research in biotechnology - Bird Flu
Carrington Reports First Quarter 2007 Results - Carrington Laboratories, Inc.
Carrington Granted Permanent Injunction Against Tom O'Brien and Center for Natural Healing - Developmental Biology
Data from The Jackson Laboratory advance knowledge in developmental biology - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
